Discontinuation of antiepileptic drugs after pediatric epilepsy surgery

D Barry Sinclair1, Laura Jurasek, Matt Wheatley

  • 1Comprehensive Epilepsy Program, University of Alberta, Edmonton, Alberta, Canada. barry.sinclair@capitalhealth.ca

Pediatric Neurology
|September 4, 2007
PubMed

Insights

Pediatric epilepsy surgery can lead to antiepileptic drug discontinuation. While less than half of children relapsed after stopping medication, success rates were higher following temporal lobe resection compared to extratemporal lobe surgery.

Area of Science:

  • Pediatric Neurology
  • Neurosurgery
  • Epileptology

Background:

  • Epilepsy surgery is a recognized treatment for medically intractable seizures in children.
  • Antiepileptic drug (AED) discontinuation after surgery is well-documented in adults but rarely studied in pediatric populations.

Purpose of the Study:

  • To evaluate surgical outcomes and the necessity of AEDs post-surgery in pediatric patients.
  • To compare AED discontinuation rates after temporal lobe resection versus extratemporal lobe resection.

Main Methods:

  • Retrospective review of 80 pediatric patients undergoing epilepsy surgery.
  • Patients were maintained on AEDs for 1 year post-surgery.
  • AED discontinuation was attempted in seizure-free patients with normal electroencephalograms (EEGs) after 1 year.

Main Results:

  • 44% of all patients relapsed after attempting AED discontinuation.
  • Relapse rates were 32% for temporal lobe resections and 55% for extratemporal lobe resections.
  • AED discontinuation success was significantly higher after temporal lobe surgery.

Conclusions:

  • Long-term AEDs are not universally required after pediatric epilepsy surgery.
  • Medication withdrawal is feasible for many children, particularly after temporal lobe resections.
  • Epilepsy surgery offers a potential pathway to reduced or eliminated AED dependence in pediatric patients.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...